Principal Financial Group Inc. Trims Stock Holdings in Nutex Health Inc. $NUTX

Principal Financial Group Inc. lowered its stake in Nutex Health Inc. (NASDAQ:NUTX) by 28.3% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,577 shares of the company’s stock after selling 4,176 shares during the quarter. Principal Financial Group Inc. owned about 0.15% of Nutex Health worth $1,005,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Hussman Strategic Advisors Inc. purchased a new stake in Nutex Health in the 4th quarter worth approximately $3,457,000. SG Americas Securities LLC lifted its holdings in Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after purchasing an additional 29,449 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Nutex Health by 78.0% during the third quarter. JPMorgan Chase & Co. now owns 14,782 shares of the company’s stock valued at $1,527,000 after purchasing an additional 6,476 shares in the last quarter. World Investment Advisors purchased a new position in Nutex Health during the fourth quarter valued at approximately $266,000. Finally, Pacer Advisors Inc. boosted its position in shares of Nutex Health by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock worth $5,480,000 after purchasing an additional 1,359 shares during the period. 5.32% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on NUTX. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday. Lake Street Capital initiated coverage on Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price target for the company. Zacks Research upgraded Nutex Health to a “hold” rating in a report on Monday, June 29th. Finally, B. Riley Financial started coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $243.33.

Nutex Health Price Performance

NUTX stock opened at $147.43 on Friday. Nutex Health Inc. has a 52 week low of $77.21 and a 52 week high of $204.00. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66. The company has a fifty day simple moving average of $154.02 and a two-hundred day simple moving average of $129.58. The firm has a market capitalization of $1.01 billion, a P/E ratio of 11.39 and a beta of 0.21.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The business had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. Analysts anticipate that Nutex Health Inc. will post 22.72 earnings per share for the current fiscal year.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.